Welcome to Markets Desk, your midweek read on the stories moving markets and money.
Eli Lilly is back in focus after Bank of America reset its price target ahead of what the street considers a pivotal catalyst for the drugmaker. Lilly carries enormous weight in the large-cap pharma space, with Zepbound and Mounjaro anchoring its obesity franchise, but analysts are watching its broader pipeline across oncology, immunology, and neuroscience as the next leg of the valuation story.
Shifting to the commodity pits, cattle futures extended their rally into a second session, with live cattle closing two dollars twenty-two to three dollars sixty-two higher on Tuesday. Cash trade has yet to fully develop this week as showlists are still being compiled, but the directional move in open interest suggests traders are watching closely for midweek price discovery to confirm the trend.
And on Capitol Hill, Republican Senator Kevin Cramer is calling for Nvidia chief executive Jensen Huang to resign, citing what he describes as extortion risks tied to Huang's alleged connection to a suspected Chinese intelligence operative. Given Nvidia's central role supplying advanced artificial intelligence chips, the senator told Politico the national security implications make the situation especially serious for the company.
That's the tape. Markets Desk, signing off the floor.
